WA-PHYSIO-CONTROL
13.1.2015 10:02:40 CET | Business Wire | Pressemeddelelse
RAV Utrecht (RAVU), the Utrecht Regional Ambulance Service, has announced that it will equip its entire emergency response fleet with LIFEPAK 15 monitor/defibrillators from Physio-Control .
The LIFEPAK 15 monitor/defibrillator is the industry leader and offers clinical efficacy, operational efficiency and excellent usability. For more than twenty years, RAVU’s emergency medical services have used LIFEPAK devices. Throughout the collaboration, Physio-Control has partnered to support the central pillars of RAVU’s service: patient-centered care, training and research.
“The LIFEPAK devices are familiar to our teams, the enhanced interfaces build upon earlier generations of LIFEPAK devices while adding important functions. They will allow for smooth transition training when they are implemented,” said Adrie Duizendstra, RAVU Facility Manager. “They are as easy to use as ever but are now more feature-rich. They are highly compatible with our electronic patient care reporting system, a feature which will make our response teams more efficient.”
“We are honored to be continuing our long-standing relationship with RAVU,” said Dré Quirijns, Physio-Control Benelux business manager. “For more than twenty years now, we have been providing RAVU with the latest technology to help them support clinical excellence and their world-class ambulance service.”
In addition to using LIFEPAK monitor/defibrillators, RAV Utrecht was also an early adopter of the Physio-Control LUCAS ® chest compression system. Performing AHA/ERC guideline-consistent chest compressions at 100 compressions per minute to a depth of 2”, LUCAS can be deployed quickly with minimal interruption to patient care. RAVU participated in a recent large randomized LINC (LUCAS In Clinical Action) clinical study led by the University of Uppsala, which compared the effectiveness of Physio-Control’s LUCAS mechanical chest compression system to high-quality manual chest compressions. Having studied and pioneered with the device for several years, RAVU are now sharing best practices with other Dutch regional ambulance systems.
“We aim to support RAVU with a complete systems approach,” said Mathieu Badard, Physio-Control Vice President and General Manager, EMEA and South Asia. “LIFEPAK monitor/defibrillators and the LUCAS chest compression system are all part of a complete system of care – a full range of resuscitation capabilities and services that we offer to our customers in order to support them in their lifesaving work.”
About the LIFEPAK ® 15 Monitor/Defibrillator
The LIFEPAK® 15 monitor/defibrillator is the standard in emergency care for advanced life support teams who want clinically innovative, operationally effective, and LIFEPAK TOUGH™ devices. More information at: www.physio-control.com/lifepak15
About Physio-Control
Physio-Control, Inc., headquartered in Redmond, Wash., USA, was founded in 1955, operates in over 100 countries and is the world’s leading provider of professional emergency medical response solutions that predict or intervene in life-threatening emergencies. The company’s products include LIFEPAK® monitor/defibrillators and automated external defibrillators, the LIFENET® System, HealthEMS® electronic patient care reporting (ePCR) software, LUCAS® 2 Chest Compression System, TrueCPRTM coaching device and implementation for PulsePoint bystander response applications. Learn more at www.physio-control.com , or via www.facebook.com/physiocontrolinc , https://www.linkedin.com/company/physio-control-inc- and Twitter: @PhysioControl .
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150113005195/en/
Contact:
Physio-Control (USA)
Matt Fikse, +1 425-867-4208
matt.fikse@physio-control.com
or
OTTO
PR (EU)
Shaun Wootton, +44 (0)7796 338360
shaun@ottopr.co.uk
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
DEWA Organises Second Agentic AI Retreat at Al Shera’a, World’s Tallest, Largest and Smartest Net‑Positive Government Building12.6.2026 17:08:00 CEST | Press release
HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA),has emphasised that DEWA deploys the latest Agentic AI technologies, in line with the vision to enhance its leading role and reinforce Dubai’s position as the city of the future. He made these remarks during the Agentic AI Executive Retreat DEWA organised at Al Shera’a, its new headquarters, which is the world’s tallest, largest and smartest net-positive government building. The event was attended by the executive leadership team and key stakeholders in digital transformation and artificial intelligence (AI), as well as representatives from SAP and McKinsey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612633834/en/ DEWA organises second Agentic AI Retreat at Al Shera’a, world’s tallest, largest and smartest net positive government building (Photo: AETOSWire) In his speech, Al Tayer said that DEWA is guided by directives from the wise l
BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 202612.6.2026 12:00:00 CEST | Press release
Tacabrutideg (BGB-16673, BTK degrader) showed durable responses in heavily pretreated R/R CLL and BTK inhibitor–naïve patients, signaling potential for earlier lines of treatmentBRUKINSA plus sonrotoclax (ZS) delivered deep, durable responses and high uMRD rates across TN CLL and R/R MCL and CLL, reinforcing its potential as an all-oral, fixed-duration treatment BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from its foundational hematology franchise at the 2026 European Hematology Association (EHA) Congress in Stockholm. Updated results from tacabrutideg (BGB-16673), a potential best-in-class Bruton’s tyrosine kinase (BTK) degrader, demonstrated durable responses in pretreated relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), with early activity also seen in BTK inhibitor–naïve patients. These data are complemented by results from the all-oral combination of BRUKINSA® (zanubru
Cyviz: Microsoft’s Immersive Approach to Collaboration12.6.2026 09:00:00 CEST | Press release
At Microsoft’s Innovation Hub in Amsterdam, immersive technology is used to enable co-creation rather than one-way presentations. In the company’s Immersive Suite, customers, data experts, and technology specialists come together in a shared environment to address complex challenges more effectively. Watch Video Case Study >> This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612831180/en/ Watch Video Case Study >> https://www.cyviz.com/case-studies/microsoft-immersive-suite/ As business and technology environments grow more complex, establishing shared understanding across disciplines has become critical. The Immersive Suite is designed for active collaboration, where visual narratives, data, and technical content are explored interactively. This allows participants to test scenarios, align perspectives, and move more efficiently from discussion to decision. “We deliberately work with familiar tools like PowerPoint. That all
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum
